Google Alert - Financial Markets

	Financial Markets As-it-happens update ⋅ February 20, 2026
	NEWS
	Dow, S&P 500, Nasdaq futures falter as US GDP cools, Fed-favored PCE inflation heats up Yahoo Finance Stock market today: Dow, S&P 500, Nasdaq futures falter as US GDP cools, Fed-favored PCE inflation heats up. Regime-sensitive dynamics in global ESG markets: Evidence from a Markov-Switching TVP ... - Springer Link Full Coverage Flag as irrelevant
	Financial Markets Wall Street | Nation - The Herald Journal Financial Markets Wall Street | Nation | hjnews.com Trader Michael Milano, right, works on the floor of the New York Stock Exchange, Friday, Feb. 20, 2026. (AP Photo/Richard Drew) Flag as irrelevant
	Capital markets finance, by other means - OMFIF OMFIF The spate of recent policy advancing capital markets union does little to address this problem. Given the reliance of European firms on bank loans, ... Capital markets for dummies: What exactly are EU leaders trying to do? - Politico.eu - Politico.eu Capital Markets & Project Finance Manager in Teaneck, NJ, United States - Qcells - Qcells Full Coverage Flag as irrelevant
	ESMA sanctions Regis-TR for serious breaches of organisational obligations | European Securities and Markets Authority - European Union The European Securities and Markets Authority (ESMA), the European Union's (EU) financial markets regulator and supervisor, has fined the trade ... Flag as irrelevant
	Oil prices jump amid signs of U.S.-Iran conflict - Axios Axios The market sees risks to both Iranian exports but also a conflict ... Data: Financial Modeling Prep; Chart: Axios Visuals. Oil prices jumped ... Flag as irrelevant
	Navigating the New World Order: A Strategic Imperative for CFOs and Treasurers - Citi Citi ... financial strategy and operational resilience. ... Periods of perceived optimism can open brief windows for capital markets issuance, often followed by ... Flag as irrelevant
	It's Official: FDA Will Now Default to One Clinical Trial for Drug Applications - BioSpace BioSpace improving likelihoods of drugs ultimately getting over the line and/or reducing late-stage development costs," RBC Capital Markets wrote in a Feb. Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback